Surgical outcome of serosa-negative advanced gastric carcinoma

Anticancer Research

Volumn 24, Issue 5 B, 2004, Pages 3169-3175

  Kunisaki, Chikara ^a,b   Shimada, Hiroshi ^a   Nomura, Masato ^a   Matsuda, Goro ^a   Otsuka, Yuichi ^a   Ono, Hidetaka ^a   Akiyama, Hirotoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Hematogenous metastasis; Lymphatic metastasis; Peritoneal metastasis; Serosa negative advanced gastric cancer

Indexed keywords

CISPLATIN; FLUOROPYRIMIDINE; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADULT; AGE; AGED; ARTICLE; BARIUM MEAL; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERITONEUM METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEROSA; STOMACH BIOPSY; STOMACH CARCINOMA; STROMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SEROUS MEMBRANE; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 6344223120     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moriguchi S, Maehara Y, Korenaga D, Sugiuchi K and Nose Y: Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1: 341-346, 1992.
2. Ikada Y, Mori M, Kamakura T et al: Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer. Cancer 73: 2459-2463, 1994.
3. Kunisaki C, Shimada H, Nomura M, Akiyama H, Matsuda G and Ono H: Indication for pancreaticosplenectomy in advanced gastric cancer. Hepato-Gastroenterol 48: 908-912, 2001.
4. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P and Meyer HJ: Prognostic factors in gastric carcinoma: results of the German Gastric Carcinoma Study 1992. Cancer 72: 2089-2097, 1993.
5. Yoo CH, Noh SH, Shin DW, Choi SH and Min JS: Recurrence following curative resection for gastric carcinoma. Br J Surg 87: 236-242, 2000.
6. Maehara Y, Moriguchi S, Kakeji Y, Kohnoe S, Korenaga D, Haraguchi M and Sugimachi K: Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 110: 820-823, 1991.
7. Hermans J, Bokkenkamp JJ, Boon CM et al: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trial. J Clin Oncol 11: 1441-1447, 1993.
8. Hirose K, Katayama K, Iida A, Yamaguchi A, Nakagawara G, Umeda S and Kusaka Y: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer evaluation by multivariate regression analysis. Oncology 57: 106-114, 1999
9. Sobin LH and Wittekind CH: International Union Against Cancer, TNM Classification of Malignant Tumors, 6th edition, New York: Wiley-Liss, 2002.
10. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma. 2nd English ed. Gastric Cancer 1: 10-24, 1998.
11. Yamamura Y, Nakajima T, Ohta K, Nashimoto A, Arai K, Hiratsuka M, Sasako M, Kodera Y and Goto M: Determining prognostic factors for gastric cancer using the regression tree method. Gastric Cancer 5: 201-207, 2002.
12. Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C and Kappas AM: Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 84: 1602-1609, 2001.
13. Kunisaki C, Shimada H, Nomura M and Akiyama H: Appropriate lymph node dissection for early gastric cancer based on lymph node metastases. Surgery 129: 153-157, 2001.
14. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T and Kato T: Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 72: 60-65, 1999.
15. Marusuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T and Ogawa M: Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: An ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res 9: 678-685, 2003.
16. Fink AS and Longmire WP: Carcinoma of stomach. In: Subiston D C (ed). Textbook of Surgery, 14th ed., pp.814-827, Philadelphia: WB Saunders, 1991.
17. Kodera Y, Nakanishi H, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Koto T and Tatematsu M: Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer Precdict Oncol 79: 429-433, 1998.
18. Ueno H, Yoshida K, Hirai T, Kono F, Kambe M and Toge T: Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real time quantitative reverse transcription polymerase chain reaction. Anticancer Res 23: 1701-1708, 2003.
19. Sakakura C, Hagiwara A, Fukuda K, Shimomura K, Takagi T, Kin S, Nakase Y, Fujiyama J, Mikoshiba K, Okazaki Y and Yamagishi H: Possible involvement of inositol 1,4,5-triphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res 23: 3691-3697, 2003.
20. Louhimo J, Finne P, Alfthan H, Stenman UH and Haglund C: Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res 22: 1759-1764, 2002.
21. Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H and Haglund C: CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 22: 2311-2316, 2002.
22. Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Sekara E, Michail P, Rosenberg T and Diamantis T: Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol 98: 478-485, 2003.
23. Fujimoto S, Takahashi M, Mutou T, Kobayashi K and Toyosawa T: Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 85: 529-534, 1999.
24. Yu W, Whang I, Chung HY, Averbach A and Sugarbaker PH: Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: Results of a randomized trial. World J Surg 25: 985-990, 2001.
25. Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M, and Matsuda G: Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 131: 521-528, 2002.
26. Kaibara N, Kimura O, Nishidoi H, Makino M, Kawasumi H and Koga S: High incidence of liver metastasis in gastric cancer with medullary growth pattern. J Surg Oncol 28: 195-8, 1985.
27. Ishihara S, Yanagisawa A, Ohta H, Ueno M, Arai M, Seki M, Kokudo N, Ohta K, Takahashi T and Nishi M: Clinicopathologic features of early gastric carcinoma with liver metastases. Jpn J Gastroenterol Surg 60: 2578-83, 1999.
28. Kunisaki C, Shimada H, Takahashi M, Nomura M, Matsuda G, Otsuka Y, Ono H and Akiyama H: Implication of extended lymph node dissection stratified for advanced gastric cancer. Anticancer Res 23: 4181-4186, 2003.